Stocks and Investing Stocks and Investing
Fri, June 28, 2024

Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $22 on, Jun 28th, 2024


Published on 2024-10-28 12:09:49 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $22 on, Jun 28th, 2024.

Joseph has made no other calls on STOK in the last 4 months.



There are 6 other peers that have a rating on STOK. Out of the 6 peers that are also analyzing STOK, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $13 on, Tuesday, March 26th, 2024


These are the ratings of the 5 analyists that currently disagree with Joseph


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, May 7th, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, May 7th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, April 4th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $17 on, Tuesday, March 26th, 2024
  • Yaron Werber of "TD Cowen" Upgraded from Hold to Strong Buy on, Tuesday, March 26th, 2024
Contributing Sources